Episode 2. Centralised and Decentralised Procedures
Play • 8 min

Different approval pathways can be explored while entering the European pharmaceutical market. The approval pathways include:

  • Centralized Procedure (CP)
  • Decentralized Procedure (DCP)
  • National Procedure (NP)
  • Mutual Recognition Procedure (MRP)

Our experts discuss the most explored pathways, CP and DCP, and the eligibility criteria to pursue them for product approval and marketing authorization within the European Union (EU). 

Reference Links

More episodes
Clear search
Close search
Google apps
Main menu